Larry Ellberger - Net Worth and Insider Trading
Larry Ellberger Net Worth
The estimated net worth of Larry Ellberger is at least $93,527 dollars as of 2024-11-10. Larry Ellberger is the Director of Celldex Therapeutics Inc and owns about 3,567 shares of Celldex Therapeutics Inc (CLDX) stock worth over $93,527. Details can be seen in Larry Ellberger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Larry Ellberger has not made any transactions after 2015-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Larry Ellberger
Larry Ellberger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Larry Ellberger owns 2 companies in total, including Celldex Therapeutics Inc (CLDX) , and Interpace Biosciences Inc (IDXG) .
Click here to see the complete history of Larry Ellberger’s form 4 insider trades.
Insider Ownership Summary of Larry Ellberger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2015-08-25 | director |
| IDXG | Interpace Biosciences Inc | 2003-12-31 | director |
Larry Ellberger Latest Holdings Summary
Larry Ellberger currently owns a total of 1 stock. Larry Ellberger owns 3,567 shares of Celldex Therapeutics Inc (CLDX) as of August 25, 2015, with a value of $93,527.
Latest Holdings of Larry Ellberger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2015-08-25 | 3,567 | 26.22 | 93,527 |
Holding Weightings of Larry Ellberger
Larry Ellberger Form 4 Trading Tracker
According to the SEC Form 4 filings, Larry Ellberger has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 333 shares on August 25, 2015, which cost Larry Ellberger around $70,000.
Insider Trading History of Larry Ellberger
- 1
Larry Ellberger Trading Performance
GuruFocus tracks the stock performance after each of Larry Ellberger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Larry Ellberger is 9.58%. GuruFocus also compares Larry Ellberger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Larry Ellberger within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Larry Ellberger's insider trading performs compared to the benchmark.
Performance of Larry Ellberger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.15 | | | | | |
| Relative Return to S&P 500(%) | 1.07 | | | | | |
Larry Ellberger Ownership Network
Ownership Network List of Larry Ellberger
Ownership Network Relation of Larry Ellberger
Larry Ellberger Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Larry Ellberger is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP & Chief Product Dev Officer Elizabeth Crowley , SVP and CFO Samuel Bates Martin , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Larry Ellberger made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,560 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Larry Ellberger Mailing Address
Above is the net worth, insider trading, and ownership report for Larry Ellberger. You might contact Larry Ellberger via mailing address: C/o Pdi Inc, Saddle River Exec Centre, 1 Rt 17 South, Saddle River Nj 07458.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
